socalTECH
SEPTEMBER 27, 2012
In a proof that it's not all social media and e-commerce here in Southern California, number two ranking startup in The Wall Street Journal's ranking of the "Top 50 Startups" is none other than wireless hardware provider Xirrus , based in Thousand Oaks. That list included Laguna Hills-based Glaukos at number 7; Donuts Inc. , READ MORE>>.
socalTECH
MARCH 3, 2011
The Wall Street Journal, at a conference in Santa Barbara this week, named its list of "Top 10" clean technology firms, naming two local companies to the list of firms with the "greatest potential to succeed." The WSJ held its ECO:nomics Executive Conference in Santa Barbara this week.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
JULY 26, 2016
Adding to the confusion, the most-recent MoneyTree Report on San Diego venture capital activity shows that Ostendo raised almost $10 million in VC funding during the second quarter. Razi, Bussel, and Dull are also on the board of Ingenu, the San Diego wireless technology company known previously as On-Ramp Wireless.
Xconomy
FEBRUARY 5, 2018
When those investors do open their wallets, they’re shunning risky investments in favor of what the Wall Street Journal called “the upper echelon of highly valued startups” such as Airbnb and WeWork. You could make a good case that these investors are taking the “venture” out of “venture capital.”
Xconomy
JUNE 12, 2018
He’s the CEO of San Diego medical device startup Tear Film Innovations, which recently raised a. Come to think of it, do your eyes feel dry? Some eye doctors are finding more cases of dry eye in young adults, and even children. That has Rob Thornill seeing opportunity. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
Xconomy
AUGUST 17, 2016
Histogen, a San Diego-based regenerative medicine company with technology for growing skin cells and related products, said it has raised $6 million from an affiliate of Huapont Life Sciences, a healthcare products company based in Chongqing, China.
Xconomy
SEPTEMBER 27, 2016
Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups).
Expert insights. Personalized for you.
145 
Let's personalize your content